eMedicine Specialties > Infectious Diseases > Parasitic Infections
Babesiosis: Differential Diagnoses & Workup
Updated: Jul 28, 2008
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Differential Diagnoses
Ehrlichiosis
Lyme Disease
Malaria
Rocky Mountain Spotted Fever
Typhoid Fever
Other Problems to Be Considered
Babesiosis usually manifests as an undifferentiated acute febrile illness that resembles malaria. Patients who previously had non– Plasmodium falciparum malaria may be experiencing a relapse of their previous malarial infection. A relapse of their malaria may be diagnosed based on prior exposure or infection as many as 40 years previously with a non-falciparum malaria. Diagnosis is based on demonstrated plasmodia in properly prepared Giemsa-stained or Wright-stained thick or thin blood smears. Patients with recrudescent malaria may have low levels of parasitemia and usually have increased malaria immunoglobulin G (IgG) titers.
Patients who present with a malarialike illness always should be questioned regarding potential for previous exposure to malaria.
Patients should also be questioned about a previous history of Lyme disease. Although the signs and symptoms of Lyme disease differ from those of babesiosis, the Ixodidae tick vector associated with Lyme disease may also transmit Babesia organisms. Co-infections of Lyme disease and babesiosis are uncommon but can occur.
Ehrlichiosis (ie, "spotless" RMSF) also presents as an acute febrile infection that resembles RMSF. Because of the separate tick vectors, patients with ehrlichiosis are unlikely to be co-infected with Lyme disease or babesiosis. While seropositivity to Lyme disease and ehrlichiosis is common in endemic areas, clinical co-infection remains rare. Increased Ehrlichia titers with an IgG antibody titer equal to or greater than 1:64 or a 4-fold or greater change in antibody titers on immunofluorescent antibody (IFA) testing is diagnostic of ehrlichiosis.
Patients with ehrlichiosis often have leukopenia, anemia, and thrombocytopenia. The erythrocyte sedimentation rate (ESR) is minimally elevated in ehrlichiosis. Levels of serum transaminases may be mildly increased in ehrlichiosis, as with babesiosis, typhoid fever, and RMSF.
Typhoid fever, RMSF, and Lyme disease may be differentiated from babesiosis, ehrlichiosis, and malaria based on the presence or absence of hemolytic anemia. Hemolytic anemia is not a typical feature of typhoid fever, RMSF, or Lyme disease.
Except for Lyme disease and typhoid fever, thrombocytopenia is a feature of all of these infectious diseases. Leukopenia is a common finding in typhoid fever, RMSF, babesiosis, and ehrlichiosis but is not a characteristic finding in Lyme disease.
Splenomegaly may be present in patients with typhoid fever, malaria, babesiosis, ehrlichiosis, and RMSF but is not a feature of Lyme disease.
Arthropod-borne viral infections may be confused with babesiosis. However, arboviral illnesses are characterized by the extreme rapidity of onset and clinical severity, which is not the case in babesiosis unless the spleen is absent.
Relative bradycardia is a cardinal finding in many infectious diseases. Many arboviral infections (eg, yellow fever, dengue fever, African hemorrhagic fever [Ebola]) are characterized by relative bradycardia. Relative bradycardia is a common finding in patients with malaria, RMSF, and babesiosis but is not a feature of Lyme disease.
In rare cases, typhoidal Epstein-Barr virus (EBV) infections, mononucleosis, or typhoidal tularemia is confused with babesiosis. EBV-specific antibody testing and tube agglutination testing for tularemia can help exclude these diagnostic possibilities if they are considered in the differential diagnoses.
Typhoid fever is suggested by a severe headache and apathetic faces with few, if any, localizing signs. Splenomegaly may be present later in the course of the illness. A normal or slightly decreased peripheral WBC count is the characteristic hematologic finding in typhoid fever. The presence of eosinophilia or thrombocytopenia suggests an alternate diagnosis. Typhoid fever may be diagnosed based on staining or culturing the organism in RES tissues or body fluid, ie, blood, urine, or feces.
Typhoid fever may resemble babesiosis and its clinical presentation. As with babesiosis, physical signs are usually absent in patients with typhoid fever. Patients with typhoid fever often present with constipation rather than diarrhea, which may be helpful because neither constipation nor diarrhea is a feature of babesiosis.
Headache is a prominent feature of malaria and typhoid fever but is less prominent with babesiosis and ehrlichiosis and is mild if present in Lyme disease.
Human monocytic ehrlichiosis (HME), human granulocytic anaplasmosis (HGA), and human granulocytic ehrlichiosis (HGE) may be diagnosed serologically in patients with a nonspecific febrile illness in endemic areas. These may also be diagnosed based on Wright stain on peripheral blood smears or buffy-coat preparations that demonstrate regularly stained cytoplasmic inclusions in monocytes or, less commonly, lymphocytes, which are mulberry-shaped and are called morulae. Morulae are seen more frequently in HME than in HGE.
Babesiosis rarely affects the lungs. However, patients with babesiosis may develop noncardiogenic pulmonary edema, which may resemble pneumonia on chest radiography.
Workup
Laboratory Studies
Patients from areas endemic for babesiosis who present with a malarialike illness should undergo a workup for babesiosis with the following direct and indirect tests.
- Lactate dehydrogenase (LDH) and a properly stained peripheral blood smear offer the most important results in patients with suspected babesiosis who have a malarialike illness. Quantitatively stained buffy-coat smears concentrate WBCs and increase the likelihood of demonstrating Babesia in the peripheral blood. As with malaria, multiple peripheral-stained thin smears or stained buffy-coat preparations may be necessary to detect low levels of Babesia parasitemia.
- Wright or Giemsa stain on thin blood smears reveals the ring forms of babesiosis. The ability to identify babesiosis depends on the expertise and experience of the microbiologist or physician and the degree of parasitemia.
- Most patients with intact splenic function who are mildly to moderately ill with babesiosis have 10% or less of parasitemia in their peripheral blood.
- Patients with asplenia usually have greater degrees of parasitemia.
- Patients with Babesia infection, in addition to having intraerythrocytic ring forms, may also demonstrate merozoites arranged in a tetrad configuration that resembles a Maltese cross.
- Tetrad forms are pathognomonic of babesiosis. Babesiosis may be differentiated from malaria based on the absence of pigment hemozoin, which is not present in babesiosis.
- Complete blood cell count and erythrocyte sedimentation rate
- A CBC count should be obtained to look for the presence of hemolytic anemia, Howell-Jolly bodies indicative of splenic dysfunction, leukopenia, lymphopenia, thrombocytopenia, and an elevated ESR.
- Hemolytic anemia, lymphopenia, and thrombocytopenia are the typical findings in babesiosis.
- Atypical lymphocytes may be present, as they are in malaria, and the number of atypical lymphocytes is not related to the degree of parasitemia or the severity of illness.
- As with malaria, the diagnosis of babesiosis should be questioned if the serum LDH level is not elevated. Increased LDH levels reflect the degree of parasitemia/severity of Babesia.
- Serum protein electrophoresis (SPEP): This test should be obtained, and results usually show a polyclonal gammopathy indicative of B-lymphocyte hyperreactivity SPEP (polyclonal gammopathy) in response to T-lymphocyte suppression by Babesia.
- Liver function tests
- LFTs should be obtained to look for elevated transaminase levels, an elevated alkaline phosphatase level, hyperbilirubinemia, and a decreased haptoglobin level. These abnormalities are variably present in patients with babesiosis.
- Obviously, the total bilirubin and haptoglobin values reflect the intensity of the infection. Increased serum transaminase levels are usually mildly and transiently elevated. A decreased haptoglobin level suggests a significant degree of intravascular hemolysis.
- Urinalysis
- Urinalysis should be obtained to check for hemoglobinuria.
- The degree of hemoglobinuria is related to the intensity of the Babesia infection.
- Serology
- Immunoglobulin M (IgM) or IgG IFA B microti titers may be obtained in patients with suspected babesiosis who have negative findings on peripheral smears, eg, low levels of parasitemia.
- A single IgM IFA titer of 1:64 or greater is diagnostic of babesiosis. Increased IgG IFA Babesia titers indicate past exposure rather than current infection.
- Serum creatinine measurements should be obtained to assess potential renal insufficiency. Care must be taken to consider other causes of an increased serum creatinine level before ascribing these changes to Babesia infection.
- Polymerase chain reaction: This test may be used to help diagnose recrudescent Babesia infection in patients who have previously had babesiosis or in those whose treatment is of questionable effectiveness.
More on Babesiosis |
| Overview: Babesiosis |
Differential Diagnoses & Workup: Babesiosis |
| Treatment & Medication: Babesiosis |
| Follow-up: Babesiosis |
| Multimedia: Babesiosis |
| References |
| « Previous Page | Next Page » |
References
Dobroszycki J, Herwaldt BL, Boctor F, et al. A cluster of transfusion-associated babesiosis cases traced to a single asymptomatic donor. JAMA. Mar 10 1999;281(10):927-30. [Medline].
Gerber MA, Shapiro ED, Krause PJ, et al. The risk of acquiring Lyme disease or babesiosis from a blood transfusion. J Infect Dis. Jul 1994;170(1):231-4. [Medline].
Jacoby GA, Hunt JV, Kosinski KS, et al. Treatment of transfusion-transmitted babesiosis by exchange transfusion. N Engl J Med. Nov 6 1980;303(19):1098-100. [Medline].
Leiby DA. Babesiosis and blood transfusion: flying under the radar. Vox Sang. Apr 2006;90(3):157-65. [Medline].
Mintz ED, Anderson JF, Cable RG. Transfusion-transmitted babesiosis: a case report from a new endemic area. Transfusion. May 1991;31(4):365-8. [Medline].
Wittner M, Rowin KS, Tanowitz HB, et al. Successful chemotherapy of transfusion babesiosis. Ann Intern Med. May 1982;96(5):601-4. [Medline].
Bakken JS, Dumler JS. Ehrlichiosis. In: Cunha BA, ed. Tickborne Infectious Diseases. New York, NY: Marcel Dekker; 2000:139-68.
Benach JL, Habicht GS, Hamburger MI. Immunoresponsiveness in acute babesiosis in humans. J Infect Dis. Sep 1982;146(3):369-80. [Medline].
Bonoan JT, Cunha BA. Babesiosis. Emerg Med. 1997;26:104.
Bonoan JT, Johnson DH, Cunha BA. Life-threatening babesiosis in an asplenic patient treated with exchange transfusion, azithromycin, and atovaquone. Heart Lung. Nov-Dec 1998;27(6):424-8. [Medline].
Boustani MR, Gelfand JA. Babesiosis. Clin Infect Dis. Apr 1996;22(4):611-5. [Medline].
Boustani MR, Lepore TJ, Gelfand JA, et al. Acute respiratory failure in patients treated for babesiosis. Am J Respir Crit Care Med. Jun 1994;149(6):1689-91. [Medline].
Boustani MR, Lepore TJ, Gelfand JA, et al. Acute respiratory failure in patients treated for babesiosis. Am J Respir Crit Care Med. Jun 1994;149(6):1689-91. [Medline].
Byrd RP Jr, Vasquez J, Roy TM. Respiratory manifestations of tick-borne diseases in the Southeastern United States. South Med J. Jan 1997;90(1):1-4. [Medline].
Cunha BA. Antibiotic Essentials. Royal Oak, Mich: Physicians Press; 2006.
Cunha BA, Nausheen S, Szalda D. Pulmonary complications of babesiosis: case report and literature review. Eur J Clin Microbiol Infect Dis. Jul 2007;26(7):505-8. [Medline].
Dodd JD, Aquino SL, Sharma A. Babesiosis: CT and hematologic findings. J Thorac Imaging. Aug 2007;22(3):271-3. [Medline].
Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis. May 1996;22(5):809-12. [Medline].
Feldman RM, Singer C. Noncardiogenic pulmonary edema and pulmonary fibrosis in falciparum malaria. Rev Infect Dis. Jan-Feb 1987;9(1):134-9. [Medline].
Gordon S, Cordon RA, Mazdzer EJ, et al. Adult respiratory distress syndrome in babesiosis. Chest. Oct 1984;86(4):633-4. [Medline].
Gorenflot A, Moubri K, Precigout E, et al. Human babesiosis. Ann Trop Med Parasitol. Jun 1998;92(4):489-501. [Medline].
Healy GR, Ruebush TK 2nd. Morphology of Babesia microti in human blood smears. Am J Clin Pathol. Jan 1980;73(1):107-9. [Medline].
Horowitz ML, Coletta F, Fein AM. Delayed onset adult respiratory distress syndrome in babesiosis. Chest. Oct 1994;106(4):1299-301. [Medline].
Hughes WT, Oz HS. Successful prevention and treatment of babesiosis with atovaquone. J Infect Dis. Oct 1995;172(4):1042-6. [Medline].
Kim N, Rosenbaum GS, Cunha BA. Relative bradycardia and lymphopenia in patients with babesiosis. Clin Infect Dis. May 1998;26(5):1218-9. [Medline].
Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, et al. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis. Feb 1 2008;46(3):370-6. [Medline].
Krause PJ, Ryan R, Telford S 3rd, et al. Efficacy of immunoglobulin M serodiagnostic test for rapid diagnosis of acute babesiosis. J Clin Microbiol. Aug 1996;34(8):2014-6. [Medline].
Krause PJ, Telford SR 3rd, Ryan R, et al. Diagnosis of babesiosis: evaluation of a serologic test for the detection of Babesia microti antibody. J Infect Dis. Apr 1994;169(4):923-6. [Medline].
Lermi A, Cunha BA. Babesiosis. Infect Dis Pract. 1998;22:12-4.
Loa CC, Adelson ME, Mordechai E, et al. Serological diagnosis of human babesiosis by IgG enzyme-linked immunosorbent assay. Curr Microbiol. Dec 2004;49(6):385-9. [Medline].
Mattia AR, Waldron MA, Sierra LS. Use of the Quantitative Buffy Coat system for detection of parasitemia in patients with babesiosis. J Clin Microbiol. Oct 1993;31(10):2816-8. [Medline].
Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis. Mar 15 2001;32(6):897-928. [Medline].
Persing DH, Mathiesen D, Marshall WF, et al. Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol. Aug 1992;30(8):2097-103. [Medline].
Poirel L, Marque S, Heritier C, et al. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. Jan 2005;49(1):202-8. [Medline].
Raju M, Salazar JC, Leopold H, et al. Atovaquone and azithromycin treatment for babesiosis in an infant. Pediatr Infect Dis J. Feb 2007;26(2):181-3. [Medline].
Raoult D, Soulayrol L, Toga B, et al. Babesiosis, pentamidine, and cotrimoxazole. Ann Intern Med. Dec 1987;107(6):944. [Medline].
Rosenbaum GS, Johnson DH, Cunha BA. Atypical lymphocytosis in babesiosis. Clin Infect Dis. Jan 1995;20(1):203-4. [Medline].
Shaio MF, Yang KD. Response of babesiosis to a combined regimen of quinine and azithromycin. Trans R Soc Trop Med Hyg. Mar-Apr 1997;91(2):214-5. [Medline].
Sharan KP, Krause PJ. Babesiosis. In: Cunha BA, ed. Tickborne Infectious Diseases. New York, NY: Marcel Dekker; 2000:111-20.
Shih CM, Wang CC. Ability of azithromycin in combination with quinine for the elimination of babesial infection in humans. Am J Trop Med Hyg. Oct 1998;59(4):509-12. [Medline].
Sun T, Chess Q, Tanenbaum B. Morphologic criteria for the identification of Pneumocystis carinii in Papanicolaou-stained preparations. Acta Cytol. Jan-Feb 1986;30(1):80-2. [Medline].
Further Reading
Keywords
babesiosis, Babesia, Babesia infection, Babesia microti, B microti, Babesia divergens, B divergens, Ixodes, Ixodes scapularis, I scapularis, Ixodes dammini, I dammini, Babesia bigemina, B bigemina, Babesia bovis, B bovis, Babesia major, B major, Babesia equi, B equi, Babesia canis, B canis, Babesia felis, B felis, Babesia microti, B microti, tick-borne infection, tick disease, tickborne illness, tick-borne illness, tick infection, malaria, Lyme disease, protozoan infection, Ixodidae, Texas cattle fever
Differential Diagnoses & Workup: Babesiosis